Dyno Therapeutics

Dyno’s CEO and Founder Eric Kelsic will be on a special panel discussion this afternoon to share his insights on how successful partnerships between pharma and biotech startups can drive scientific discovery and accelerate therapeutic development. Join live or over zoom 5-7PM ET. Sign up here 👉 https://lu.ma/gjzn3ktp

Congratulations to our partners at NVIDIA on announcing the #opensource BioNeMo framework – an exciting leap forward in the era of #digitalbiology. We’re thrilled to continue working together in leveraging supercomputing to accelerate advance #drugdiscovery through accelerated sequence design. Learn more 👉 https://lnkd.in/es7R7PkN

Dyno’s CEO and Founder Eric Kelsic will be joining gene therapy experts at the University of Florida Genetics Institute this Thursday to give a talk on the cutting edge of applying artificial intelligence to solving gene delivery. Learn more about the event here: https://lnkd.in/emZWG-cc

If you’re in NYC this Saturday, come catch Dyno’s Head of Machine Learning Sam Sinai at the MIT AI conference! Sam will be on a panel discussing the real world applications of AI in healthcare, and share his insights on the ML technologies that are foundational to Dyno’s success.

This morning Gerry Smith of Bloomberg News sat down with Eric Kelsic to talk about Dyno’s new partnership with Roche, and the importance of finding concrete solutions to in vivo gene delivery to enable accessible therapies for patients. Read the article here: https://lnkd.in/e9G3yTaC

We’re thrilled to announce a new strategic partnership with Roche to advance next-generation #AAV gene therapies for neurological diseases. Since starting our relationship with Roche in 2020, Dyno has made tremendous progress towards finding concrete solutions to in vivo gene delivery through the application of AI models for sequence-function prediction. We’re excited to further our collaboration with Roche and continue working together towards a future where all gene therapies are safe, effective, and accessible to all patients who need them. More on this partnership milestone here: https://lnkd.in/eQ2AGndV

Today, Dyno is excited to open source Liminal ORM! Liminal is a python library which streamlines laboratory information management by synchronizing codebases with #Benchling schemas using a single source of truth. Implementing this package has already provided tremendous value to Dyno’s AI-powered capsid design platform by reducing time spent on complex system changes, and eliminating system misalignment. We’re excited to share Liminal with the community and see the impact it will have on your projects! Learn more and start using Liminal by going to Dyno’s github: https://lnkd.in/ej5vqs9k

🌟 We're hiring! Join us at Dyno Therapeutics to shape the future of gene therapy 🚀 We're on the lookout for individuals ready to make waves in the world of gene therapy. If you have a passion for pushing boundaries and leading teams of extremely talented people, we have exciting opportunities for you: 🔬 Sr. Scientist - CNS Capsid Validation Are you a trailblazer in gene therapy and NGS? Bring your expertise and people management skills to play a pivotal role in deploying Dyno's molecular assays for critical preclinical studies! 🔬 Sr. Scientist - AAV Capsid Engineering Calling all viral vector visionaries! If you have a knack for viral production and a flair for leading teams at the bench, we want you to steer our AAV production efforts into new territories. ⚖️ Associate Director/Director of Intellectual Property (IP) Shape the future of our IP landscape! Work collaboratively across teams to strategically safeguard our innovations and propel our mission of advancing gene therapy breakthroughs. Ready to embark on this journey with us? Apply now through our website and be part of a team that’s redefining what’s possible in the gene therapy space! ✨ #dyno #dynotherapeutics #biotechjobs #nowhiring #seniorscientist #bostonbiotech #genetherapy

Today, Dyno is excited to open source Liminal ORM! Liminal is a python library which streamlines laboratory information management by synchronizing codebases with #Benchling schemas using a single source of truth. Implementing this package has already provided tremendous value to Dyno’s AI-powered capsid design platform by reducing time spent on complex system changes, and eliminating system misalignment. We’re excited to share Liminal with the community and see the impact it will have on your projects! Learn more and start using Liminal by going to Dyno’s github: https://lnkd.in/ej5vqs9k

Dyno’s capsid design models are some of the most precise in the gene therapy space, and are built on tremendous amounts of complex data to make their predictions. Come learn from Dyno’s Engineering Team Lead about the data infrastructure innovations which keep these models running, and be the first to hear about a new Dyno code release 👀🧑💻! David Levy-Booth will be presenting on the Dyno bioML data platform this Monday Oct 21 from 1:20 - 1:40 PM at the LatchBio Data Infrastructure for Biotech Conference. Don’t miss it! https://lnkd.in/eRWPPXgp